+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novavax Inc - logo

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

COVID-19 Vaccines - Global Strategic Business Report - Product Thumbnail Image

COVID-19 Vaccines - Global Strategic Business Report

  • Report
  • April 2024
  • 762 Pages
  • Global
From
United States Influenza Vaccines Market Size, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2031 - Product Thumbnail Image

United States Influenza Vaccines Market Size, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2031

  • Report
  • March 2023
  • 220 Pages
  • United States
From
COVID-19 Vaccines Market Size, Trends and Analysis by Disease Overview, Epidemiology, Unmet Needs and Opportunities, Therapeutic Landscape, Pipeline Assessment, Clinical Trial Strategies and Forecast to 2026 - Product Thumbnail Image

COVID-19 Vaccines Market Size, Trends and Analysis by Disease Overview, Epidemiology, Unmet Needs and Opportunities, Therapeutic Landscape, Pipeline Assessment, Clinical Trial Strategies and Forecast to 2026

  • Report
  • August 2023
  • 79 Pages
  • Global
From
Influenza Vaccines: Global Markets - Product Thumbnail Image

Influenza Vaccines: Global Markets

  • Report
  • May 2022
  • 109 Pages
  • Global
From
Global Vaccine Adjuvants Market Size, Share & Trends Analysis Report by Type (Pathogen, Adjuvant Emulsion, Particulate), Administration (Oral, Intradermal, Intranasal, Intramuscular), Application, Region, and Segment Forecasts, 2023-2030 - Product Thumbnail Image

Global Vaccine Adjuvants Market Size, Share & Trends Analysis Report by Type (Pathogen, Adjuvant Emulsion, Particulate), Administration (Oral, Intradermal, Intranasal, Intramuscular), Application, Region, and Segment Forecasts, 2023-2030

  • Report
  • November 2023
  • 120 Pages
  • Global
From
Viral Vaccine Cell Culture Media Market Distribution by Type of Cell Culture, Type of Media, Scale of Operation, Type of End-User, and Key Geographical Regions : Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Viral Vaccine Cell Culture Media Market Distribution by Type of Cell Culture, Type of Media, Scale of Operation, Type of End-User, and Key Geographical Regions : Industry Trends and Global Forecasts, 2022-2035

  • Report
  • March 2022
  • 180 Pages
  • Global
From
COVID-19 (Coronavirus) Global Market Conditions and Competitors: Cell Therapies, Diagnostics, Treatments, Trials, & Vaccines - Product Thumbnail Image

COVID-19 (Coronavirus) Global Market Conditions and Competitors: Cell Therapies, Diagnostics, Treatments, Trials, & Vaccines

  • Report
  • July 2020
  • 269 Pages
  • Global
From
The World Market for Vaccines, 2024 - Product Thumbnail Image

The World Market for Vaccines, 2024

  • Report
  • February 2024
  • 202 Pages
  • Global
From
COVID-19 Vaccine Market - Global Outlook and Forecast 2021-2024 - Product Thumbnail Image

COVID-19 Vaccine Market - Global Outlook and Forecast 2021-2024

  • Report
  • March 2021
  • Global
From
Vaccine Contract Manufacturing Market by Business Operations, Type of Expression Systems, Company Size, Scale of Operation, and Geography: Industry Trends and Global Forecasts, 2021-2030 - Product Thumbnail Image

Vaccine Contract Manufacturing Market by Business Operations, Type of Expression Systems, Company Size, Scale of Operation, and Geography: Industry Trends and Global Forecasts, 2021-2030

  • Report
  • May 2021
  • 381 Pages
  • Global
From
SARS-CoV-2 COVID Vaccine Market Analysis & Forecast to 2026 - Product Thumbnail Image

SARS-CoV-2 COVID Vaccine Market Analysis & Forecast to 2026

  • Report
  • March 2021
  • 137 Pages
  • Global
From
Global Infectious Vaccines Market by Product (Preventive Vaccine, Therapeutic Vaccine), Infectious Disease (Allergy, Cervical Cancer, DTP), End User - Forecast 2024-2030 - Product Thumbnail Image

Global Infectious Vaccines Market by Product (Preventive Vaccine, Therapeutic Vaccine), Infectious Disease (Allergy, Cervical Cancer, DTP), End User - Forecast 2024-2030

  • Report
  • March 2024
  • 183 Pages
  • Global
From
Global Vaccine Adjuvants Market by Product (Adjuvant Emulsions, Combination Adjuvants, Mineral Adjuvants), Route of Administration (Intradermal, Intramuscular, Intranasal), Disease, Application - Forecast 2024-2030 - Product Thumbnail Image

Global Vaccine Adjuvants Market by Product (Adjuvant Emulsions, Combination Adjuvants, Mineral Adjuvants), Route of Administration (Intradermal, Intramuscular, Intranasal), Disease, Application - Forecast 2024-2030

  • Report
  • March 2024
  • 197 Pages
  • Global
From
Global Preventive Vaccines Market, 2020-2030 - Product Thumbnail Image

Global Preventive Vaccines Market, 2020-2030

  • Report
  • April 2020
  • 248 Pages
  • Global
From
Global Malaria Vaccine Market by Type (Erythrocytic Vaccine, Multi-Antigen Vaccine, Pre-Erythrocytic Vaccine), Agent (Anopheles Species, Plasmodium Falciparum, Plasmodium Vivax), End-User - Forecast 2024-2030 - Product Thumbnail Image

Global Malaria Vaccine Market by Type (Erythrocytic Vaccine, Multi-Antigen Vaccine, Pre-Erythrocytic Vaccine), Agent (Anopheles Species, Plasmodium Falciparum, Plasmodium Vivax), End-User - Forecast 2024-2030

  • Report
  • March 2024
  • 193 Pages
  • Global
From
Global COVID-19 Vaccines Market by Product Type (Monovalent Vaccine, Multivalent Vaccine), End-User (Academic & Research Centers, Clinics, Hospitals), Patient Type - Forecast 2024-2030 - Product Thumbnail Image

Global COVID-19 Vaccines Market by Product Type (Monovalent Vaccine, Multivalent Vaccine), End-User (Academic & Research Centers, Clinics, Hospitals), Patient Type - Forecast 2024-2030

  • Report
  • March 2024
  • 195 Pages
  • Global
From
Global Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA (mRNA) Vaccines), Indication, Route of administration, Age Group - Forecast 2024-2030 - Product Thumbnail Image

Global Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA (mRNA) Vaccines), Indication, Route of administration, Age Group - Forecast 2024-2030

  • Report
  • March 2024
  • 181 Pages
  • Global
From
Global Vaccine Adjuvants Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global Vaccine Adjuvants Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Global Recombinant Vaccines Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global Recombinant Vaccines Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • November 2023
  • 270 Pages
  • Global
From
Loading Indicator